Nitro Spray Recalled Due to Possible Defective Delivery System Nitro Spray Recalled Due to Possible Defective Delivery System
Padagis US LLC says there is a remote risk that the product may not properly dispense nitroglycerin, rendering the medicine potentially ineffective.News Alerts (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - December 28, 2021 Category: Cardiology Tags: Cardiology News Alert Source Type: news

Padagis Issues Voluntary Nationwide Recall for Nitroglycerin Lingual Spray Due to a Possible Defective Delivery System
December 27, 2021 – Padagis US LLC announced today it has issued a voluntary nationwide recall to the consumer/user level of the lots of Nitroglycerin Lingual Spray listed in the table below. Out of an abundance of caution, this product is being recalled from the market due to a complaint received t (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - December 27, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

MR ASAP: No Benefit of Prehospital Nitroglycerin in Stroke MR ASAP: No Benefit of Prehospital Nitroglycerin in Stroke
Giving transdermal nitroglycerin to stroke patients in the ambulance within 3 hours of symptom onset was not shown to be of any benefit in the MR ASAP trial, which was stopped early owing to futility.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - September 7, 2021 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news

Transderm Nitro (Nitroglycerin) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - July 27, 2021 Category: Drugs & Pharmacology Source Type: news

On nitroglycerin, cardiovascular homeostasis and...bam, migraine!
(International Headache Society) Researchers in Leiden, The Netherlands, found an exaggerated cardiovascular response to nitroglycerin infusion in migraine patients, suggesting an elevated systemic sensitivity to this compound in this population. Also, corroborating previous studies, nitroglycerin was shown to be a consistent migraine-provoking substance. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 27, 2019 Category: International Medicine & Public Health Source Type: news

Minitran (Nitroglycerin Transdermal Delivery System) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - August 15, 2019 Category: Drugs & Pharmacology Source Type: news

Advanced Pharma, Inc. D/B/A Avella of Houston Issues Voluntary Nationwide Recall of All Unexpired Nitroglycerin Injection In 5% Dextrose USP Products Produced At Its Houston Location From March 3, 2017 Through May 31, 2017 Due To Sub-Potency
Advanced Pharma, Inc. d/b/a Avella of Houston ( “Advanced Pharma”) is voluntarily recalling all unexpired lots of Nitroglycerin products that were produced at Advanced Pharma’s Houston location between March 3, 2017 and May 31, 2017 to the hospital/user level. The recall is being issued based on laboratory test results indicating a lower t han expected potency on certain lots of compounded NitroGlycerin Injection which would lead to a lower dose being administered. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - July 25, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Medical News Today: What to know about nitroglycerin
Nitroglycerin is a drug that primarily treats a specific chest pain that doctors call angina. Learn about when they prescribe it, how it works to relieve angina, safe dosages, risks, and side effects here. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - May 17, 2019 Category: Consumer Health News Tags: Cardiovascular / Cardiology Source Type: news

BP Lowering on Way to Hospital a Fail in Acute Stroke (CME/CE)
(MedPage Today) -- Ambulance-based RIGHT-2 trial shows no benefit from nitroglycerin patch to treat elevated blood pressure (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - February 13, 2019 Category: Cardiology Source Type: news

RIGHT-2: No Benefit of Prehospital Nitroglycerin Patch in Stroke RIGHT-2: No Benefit of Prehospital Nitroglycerin Patch in Stroke
The neutral results in ischemic stroke and TIA are disappointing after earlier positive data, and suggestions of a positive and negative effect of nitroglycerin further complicate the interpretation.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 7, 2019 Category: Consumer Health News Tags: Cardiology News Source Type: news

BP Lowering en Route to Hospital Flops in Acute Stroke
(MedPage Today) -- RIGHT-2 trial shows no benefit, possible harm from nitroglycerin patch (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - February 7, 2019 Category: Cardiology Source Type: news

Ambulance nitroglycerin patch to lower blood pressure did not improve stroke outcomes
(American Heart Association) Despite the promise of earlier small studies, a patch to lower stroke patient's blood pressure before reaching the hospital didn't improve stroke outcomes. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 6, 2019 Category: International Medicine & Public Health Source Type: news

Not Just Acid Reflux: The Need to Think Worst First
Discussion Heart disease is the leading cause of death in the United States.1 This year, 720,000 Americans will have a new coronary event—defined as first hospitalized myocardial infarction (MI) or coronary heart disease death—and around 335,000 will have a recurrent event. Approximately 35% of people who experience a coronary event in a given year and around 14% of patients who have an acute coronary syndrome will die from it.1 Roughly 60% of patients with an acute coronary syndrome are transported to the emergency department via ambulance.2–4. Up to one-third of patients experiencing an MI may not complain of chest...
Source: JEMS Special Topics - January 13, 2019 Category: Emergency Medicine Authors: Stephen Sanko, MD, FACEP Tags: Exclusive Articles Cardiac & Resuscitation Source Type: news

Transdermal Nitroglycerin May Help Ease Tendon Pain Transdermal Nitroglycerin May Help Ease Tendon Pain
Nitroglycerin patches help patients with common injuries to tendons, a research review suggests.Reuters Health Information (Source: Medscape Orthopaedics Headlines)
Source: Medscape Orthopaedics Headlines - November 16, 2018 Category: Orthopaedics Tags: Anesthesiology News Source Type: news

Nitroglycerin patches may help ease tendon pain
(Reuters Health) - Patches containing nitroglycerin may help patients with common injuries to tendons, a research review suggests. (Source: Reuters: Health)
Source: Reuters: Health - November 14, 2018 Category: Consumer Health News Tags: healthNews Source Type: news